Corrigendum to “Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies” [Cancer Treat. Rev. 139 (2025) 102980]

Cancer Treatment Reviews · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles